NCT06325046 - Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer | Biotech Hunter

Enrollment

144

Participants

Timeline

Start Date

August 15, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions

Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage III Prostate Cancer AJCC v8

Interventions

PROCEDURE

Computed Tomography

Undergo CT

PROCEDURE

Cone-Beam Computed Tomography

Undergo CBCT

RADIATION

Image-Guided Adaptive Radiation Therapy

Undergo near margin-less ART

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

PROCEDURE

Stereotactic Ablative Radiotherapy

Undergo standard SABR

OTHER

Survey Administration

Ancillary studies

Trial Locations (5)

RECRUITING

Mayo Clinic Health System-Franciscan Healthcare, La Crosse

RECRUITING

Mayo Clinic Health System-Eau Claire, Eau Claire

RECRUITING

Mayo Clinic in Rochester, Rochester

RECRUITING

Mayo Clinic Health System-Mankato, Mankato

RECRUITING

Mayo Clinic Health System in Albert Lea, Albert Lea